Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, Fla.
Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2274-2279. doi: 10.1016/j.jaip.2022.04.040. Epub 2022 May 13.
The appropriate at-home management of anaphylaxis begins with patient education on recognition and treatment, especially when and how to use epinephrine. Delayed administration of epinephrine as well as having severe symptoms and needing multiple doses of epinephrine to treat symptoms are risk factors for biphasic anaphylaxis. The successful implementation of at-home management of anaphylaxis requires appropriate patient selection and an algorithmic approach that recommends activation of emergency medical services (EMS) when the patient does not adequately respond to at-home administration of epinephrine or there are extenuating patient-related circumstances. Fortunately, approximately 98% of anaphylactic episodes respond to 2 or fewer doses of epinephrine, the standard prescription used for epinephrine autoinjectors; fatal anaphylaxis is very rare, as low as 0.002 deaths/million person-years; and biphasic reactions are uncommon (∼5%), and only extremely rarely lethal. Thus, most common concerns leading to recommended EMS activation and emergency department visits after epinephrine administration are generally unsubstantiated. Furthermore, emergency department visits do not always lead to better treatment and drive health care costs higher. Open communications with patients and families regarding risks and benefits of at-home management and observation versus EMS activation and emergency department evaluation after epinephrine administration for anaphylaxis are essential. However, we believe the data indicate that it is time to reconsider the often used and taught approach that recommends EMS activation whenever epinephrine is used.
过敏反应的适当家庭管理始于对识别和治疗的患者教育,特别是何时以及如何使用肾上腺素。肾上腺素延迟给药以及症状严重且需要多次给予肾上腺素来治疗症状是双相过敏反应的危险因素。过敏反应家庭管理的成功实施需要适当的患者选择和算法方法,该方法建议在患者对家庭给予肾上腺素治疗反应不佳或存在加重的与患者相关的情况下,激活紧急医疗服务(EMS)。幸运的是,大约 98%的过敏反应发作对 2 或更少剂量的肾上腺素有反应,这是肾上腺素自动注射器的标准处方;致命的过敏反应非常罕见,每百万分之 0.002 人死亡;双相反应很少见(约 5%),且仅极其罕见致命。因此,在给予肾上腺素后建议激活 EMS 和前往急诊科就诊的最常见的担忧通常是没有根据的。此外,急诊科就诊并不总是会带来更好的治疗效果,并导致医疗保健费用更高。与患者和家属进行有关过敏反应家庭管理和观察与肾上腺素给药后 EMS 激活和急诊科评估的风险和益处的开放沟通至关重要。然而,我们认为数据表明,现在是时候重新考虑通常使用和教授的方法,即每当使用肾上腺素时都建议激活 EMS。